Recent Updates
Recently added Catalysts
COLL Positive Sentiment

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Thursday, July 20, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Collegium Pharmaceutical, Inc. will announce its financial results for the second quarter of 2023 on August 3, 2023, after market close. The company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss these results. This announcement reflects Collegium’s commitment to transparency and communication with its investors.
Price reaction · baseline $21.73 (2023-07-19 close) · hit after-hours · clean, no other COLL news in the window
day 0 close · peak
+1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Collegium is committed to improving lives of people with serious medical conditions.
  • The company is actively communicating financial results and hosting a conference call.
  • The upcoming financial report could provide insights into the company's performance.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

STOUGHTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report second quarter 2023 financial results after the market closes on Thursday, August 3, 2023. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2023 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Christopher James, M.D.

Frequently Asked Questions

When will Collegium report its Q2 2023 financial results?

Collegium will report its Q2 2023 financial results on August 3, 2023.

What time is the conference call for Q2 2023 results?

The conference call will be held at 4:30 p.m. ET on August 3, 2023.

How can I access the conference call?

Dial (877) 407-8037 for U.S. participants or (201) 689-8037 internationally.

Where can I find the webcast of the earnings call?

The webcast will be available on Collegium's Investors section of their website.

What is Collegium Pharmaceutical's focus?

Collegium Pharmaceutical is dedicated to improving lives affected by serious medical conditions.

ShareAdd on Google
Tags: COLL Viatris Investor Conferences Healthcare Collegium Pharmaceutical Q2 2023 financial results conference call specialty pharmaceuticals
Last updated: Jul 20, 2023

Biotech snapshot

Cash runway
$150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DFN-15 ActivePhase 3
Migraine Headache →

Catalyst track record

+28%
best trade around COLL's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for COLL.

See every catalyst's timing & PoA →